Log In
Print this Print this

TBI 304H

  Manage Alerts
Collapse Summary General Information
Company Therapure Biopharma Inc.
DescriptionHumanized mAb targeting the CD163 receptor pathway
Molecular Target CD163
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationAnemia
Indication DetailsTreat anemia; Treat chemotherapy induced anemia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today